Bei Coxarthrose sieht die Therapie nicht pharmakologische und pharmakologische Behandlungen vor. Diese Übersicht stellt die aktuelle Literatur zur intraartikulären Coxarthrosetherapie vor.
Literatur
Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 1988;10:1–28
Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, Hunder GG, Liang MH, Pillemer SR, Steen VD et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778–99
Solignac M. COART France 2003 report on new socioeconomic data on osteoarthritis in France. Presse Med 2004;33:S4–6
Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, Hauselmann HJ, Herrero-Beaumont G, Jordan K, Kaklamanis P, Leeb B, Lequesne M, Lohmander S et al. EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) Ann Rheum Dis 2005;64:669–81
Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137–62
Steinmeyer J, Bock F, Stöve J, Jerosch J, Flechtenmacher J. Pharmacological treatment of knee osteoarthritis: Special consideration of the new german guideline. Orthopedic Reviews 2018;10(7782)147-54
Sperati A, Picconi O, Tancioni V, Guasticchi G, Agabiti N. Outcomes of hip replacement: a hospital-based longitudinal study in Lazio region. Ann Ig 2008;20:141–57
Rotbauer F, Zerwes U, Bleß HH et al. Häufigkeit endoprothetischer Hüft- und Knieoperationen. In: Weißbuch Gelenkersatz. Versorgungssituation bei endoprothetischen Hüft- und Knieoperationen in Deutschland. Berlin, Heidelberg, New York 2017
Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Mullner M. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 2005;172:1039–43
Bannuru RR, Natov NS, Obadan IE, Price LL, Schmid CH, McAlindon TE. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum 2009;61:1704–11
Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage 2006;14:163–70
Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2003;290:3115–21
Jerosch J. Injektionsbehandlung mit Hyaluronsäure. Zeitschrift für Rheumatologie, 2015;74:764–3
Henrotin Y, Raman R, Richette P, Bard H, Jerosch J, Conrozier T, Chevalier X, Migliore A. Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis. Seminars in Arthritis and Rheumatism 2015;45:140–9
Raman R, Yves Henrotin, Xavier Chevalier, Alberto Migliore, Jörg Jerosch, Jordi Montfort, Hervé Bard, Dominique Baron, Pascal Richette, Thierry Conrozier: Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis: Recommendations from the EUROpean Viscosupplementation Consensus Group (EUROVISCO). Cartilage 2017;1–13, DOI: https://doi.org/10.1177/1947603517693043
Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 2003;5:54–67
Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage 2005;13:216–24
Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis—meta-analysis. Osteoarthritis Cartilage 2011;19:611–9
Wu B, Li YM, Liu YC. Efficacy of intra-articular hyaluronic acid injections in hip osteoarthritis: a meta-analysis of randomized controlled trials. Oncotarget 2017;8(49):86865–76
Brocq O, Tran G, Breuil V, Grisot C, Flory P, Euller-Ziegler L. Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 2002;69:388–91
Conrozier T, Bertin P, Mathieu P, Charlot J, Bailleul F, Treves R, Vignon E, Chevalier X. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. Clin Exp Rheumatol 2003;21:605–10
Migliore A, Martin LS, Alimonti A, Valente C, Tormenta S. Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 2003;11:305–6
Battaglia, M, Guaraldi, F, Vannini, F, Rossi, G, Timoncini, A, Buda, R and Giannini, S. Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics 2013;36(12):e1501–8
Dallari, D, Stagni, C, Rani, N, Sabbioni, G, Pelotti, P, Torricelli, P, Tschon, M and Giavaresi, G. Ultrasound-Guided Injection of Platelet-Rich Plasma and Hyaluronic Acid, Separately and in Combination, for Hip Osteoarthritis: A Randomized Controlled Study. Am J Sports Med 2016;44(3):664–71
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jerosch, J. Effektivität der Injektionsbehandlung bei Coxarthrose. Orthop. Rheuma 22, 39–41 (2019). https://doi.org/10.1007/s15002-019-1720-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15002-019-1720-6